Digestive Diseases and Sciences

, Volume 58, Issue 3, pp 807–814 | Cite as

Electronic Messages Increase Hepatitis B Screening in At-Risk Asian American Patients: A Randomized, Controlled Trial

  • Leeyen Hsu
  • Christopher L. Bowlus
  • Susan L. Stewart
  • Tram Thanh Nguyen
  • Julie Dang
  • Brian Chan
  • Moon S. ChenJr.
Original Article
First Online:
Received:
Accepted:

Abstract

Background

Hepatitis B (HBV) induced hepatocellular carcinoma is the greatest cancer health disparity affecting Asian Americans, but the prevalence of screening to detect HBV is suboptimal.

Aims

Our aims were to determine the effectiveness of electronic health record (EHR) prompts to increase ordering of HBV tests among primary care providers (PCPs) within an academic health system.

Methods

We conducted a randomized, controlled trial between April and June 2011 among 76 PCPs caring for 175 outpatient adults with Chinese or Vietnamese surnames, with appointments with providers and no history of HBV testing. Providers were randomized to either receive an EHR prompt for HBV testing prior to patients’ appointments or usual care. Primary outcomes were the proportion of patients (1) whose physician ordered a HBsAg test and (2) who completed testing. Secondary outcomes were (A) test results and (B) whether the physicians followed-up on the results.

Results

HBsAg tests were ordered for 36/88 (40.9 %) of the intervention patients and 1/87 (1.1 %) of the control patients [χ 2 (df = 1) = 41.48, p < 0.001]. Thirty intervention patients (34.1 %) and no control patients completed the HBsAg test [χ 2 (df = 1) = 35.80, p < 0.001]. Four (13.3 %) of the completed tests were HBsAg-positive, 14 (46.7 %) were immune, and 12 (40 %) were unprotected from HBV. Two HBsAg-positive patients were referred to specialists, and 3 unprotected patients were vaccinated for HBV.

Conclusions

EHR-based provider prompts significantly increased HBV testing in Chinese and Vietnamese patients when compared to “usual care.” EHR prompts are a promising intervention that could significantly increase screening for HBV.

Keywords

Hepatitis B Asian-American Hepatocellular carcinoma Electronic health record 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This study was supported in part by the UC Davis School of Medicine Office of the Dean and P01CA109091-A1 from the National Cancer Institute and the National Institute on Minority Health and Health Disparities. However, the views expressed are those of the authors and do not necessarily reflect the views of the National Institutes of Health.

Conflict of interest

Dr. Bowlus receives research support and consulting fees from Bristol Myers Squibb and Gilead.

References

  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from http://globocan.iarc.fr [accessed 24 Sep 2011].
  2. 2.
    Siegel R, Ward E, Brawly O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236.PubMedCrossRefGoogle Scholar
  3. 3.
    Miller BA, Chu KG, Hanley BF, Ries LA. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control. 2008;19:227–256.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen MS Jr. Cancer health disparities among Asian Americans: what we do and what we need to do. Cancer. 2005;104:2895–2902.PubMedCrossRefGoogle Scholar
  5. 5.
    Chang ET, Keegan THM, Gomez SL, et al. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer. 2007;109:2100–2108.PubMedCrossRefGoogle Scholar
  6. 6.
    McCracken M, Olsen M, Chen MS Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190–205.PubMedCrossRefGoogle Scholar
  7. 7.
    Hwang JP, Hassan MM. Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation. BMC Cancer. 2009;9:46.PubMedCrossRefGoogle Scholar
  8. 8.
    Chen JG, Parkin DM, Chen QG, et al. Screening for liver cancer: results of a randomized controlled trial in Qigong, China. J Med Screen. 2003;10:204–209.PubMedCrossRefGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR. 2008;57:1–21.Google Scholar
  10. 10.
    Taylor VM, Jackson JC, Pineda M, Pham P, Fischer M, Yasui Y. Hepatitis B knowledge among Vietnamese immigrants: implications for prevention of hepatocellular carcinoma. J Cancer Educ. 2000;15:51–55.PubMedGoogle Scholar
  11. 11.
    Taylor VM, Tu SP, Woodall E, et al. Hepatitis B knowledge and practices among Chinese immigrants to the United States. Asian Pac J Cancer Prev. 2006;7:313–317.PubMedGoogle Scholar
  12. 12.
    Taylor VM, Choe JH, Yasui Y, Li L, Burke N, Jackson JC. Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women. J Community Health. 2005;30:477–490.PubMedCrossRefGoogle Scholar
  13. 13.
    Thompson MJ, Taylor VM, Jackson JC, et al. Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington. J Cancer Educ. 2002;17:222–226.PubMedGoogle Scholar
  14. 14.
    Wu CA, Lin SY, So SK, Chang ET. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev. 2007;8:127–134.PubMedGoogle Scholar
  15. 15.
    Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18:377–383.PubMedCrossRefGoogle Scholar
  16. 16.
    Maddrey WC. Hepatitis B, an important public health issue. J Med Virol. 2000;61:362–366.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;11:1733–1745.CrossRefGoogle Scholar
  18. 18.
    World Health Organization. Hepatitis B. Department of Communicable Diseases Surveillance and Response. <http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf> Accessed 14 Feb 2012.
  19. 19.
    Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for the Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press; 2010.Google Scholar
  20. 20.
    Bastani R, Glenn BA, Taylor VM, et al. Integrating theory into community interventions to reduce liver cancer disparities: the health behavior framework. Prev Med. 2010;50:63–67.PubMedCrossRefGoogle Scholar
  21. 21.
    Chen H, Tu SP, Teh CZ, et al. Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention. J Community Health. 2006;31:94–112.PubMedCrossRefGoogle Scholar
  22. 22.
    Tran TT. Understanding cultural barriers in hepatitis B virus infection. Cleve Clin J Med. 2009;76:S10–S13.PubMedCrossRefGoogle Scholar
  23. 23.
    Taylor VM, Yasui Y, Burke N, et al. Hepatitis B testing among Vietnamese American men. Cancer Detect Prev. 2004;28:170–177.PubMedCrossRefGoogle Scholar
  24. 24.
    Coronado GD, Taylor VM, Tu SP, et al. Correlates of hepatitis B testing among Chinese Americans. J Community Health. 2007;32:379–390.PubMedCrossRefGoogle Scholar
  25. 25.
    Bazargan M, Bazargan SH, Calderon JL, Husaini BA, Baker RS. Mammography screening and breast self-examination among minority women in public housing projects: the impact of physician recommendations. Cell Mol Biol. 2003;49:1213–1218.PubMedGoogle Scholar
  26. 26.
    Chang ET, Nguyen BH, So SK. Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev. 2008;9:605–613.PubMedGoogle Scholar
  27. 27.
    Taylor VM, Jackson JC, Tu SP, et al. Cervical cancer screening among Chinese Americans. Cancer Detect Prev. 2002;26:139–145.PubMedCrossRefGoogle Scholar
  28. 28.
    Taylor VM, Schwartz SM, Yasui Y, et al. Pap testing among Vietnamese women: health care system and physician factors. J Community Health. 2004;29:437–450.PubMedCrossRefGoogle Scholar
  29. 29.
    Nguyen TT, McPhee SJ, Stewart S, et al. Factors associated with hepatitis B testing among Vietnamese Americans. J Gen Intern Med. 2010;25:694–700.PubMedCrossRefGoogle Scholar
  30. 30.
    Persell SD, Kaiser D, Dolan NC, et al. Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement. Med Care. 2011;49:117–125.PubMedCrossRefGoogle Scholar
  31. 31.
    Jimbo M, Nease DE Jr, Ruffin MT IV, Rana GK. Information technology and cancer prevention. CA Cancer J Clin. 2006;56:26–36.PubMedCrossRefGoogle Scholar
  32. 32.
    Mandelblatt JS, Yabroff KR. Effectiveness of interventions designed to increase mammography use: a meta-analysis of provider-targeted strategies. Cancer Epidemiol Biomarkers Prev. 1999;8:759–767.PubMedGoogle Scholar
  33. 33.
    McPhee SJ, Bird JA, Fordham D, Rodnick JE, Osborn EH. Promoting cancer prevention activities by primary care physicians: results of a randomized, controlled trial. JAMA. 1991;266:538–544.PubMedCrossRefGoogle Scholar
  34. 34.
    Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin. 2007;57:354–366.PubMedCrossRefGoogle Scholar
  35. 35.
    Vinker S, Nakar S, Rosenberg E, Kitai E. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study. Isr Med Assoc J. 2002;4:424–425.PubMedGoogle Scholar
  36. 36.
    Lauderdale DS, Kestenbaum B. Asian American ethnic identification by surname. Popul Res Policy Rev. 2000;19:283–300.CrossRefGoogle Scholar
  37. 37.
    Choe JH, Taylor VM, Yasui Y, et al. Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men. J Immigr Minor Health. 2006;8:193–201.PubMedCrossRefGoogle Scholar
  38. 38.
    Khalili M, Guy J, Yu A, Li A, et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011;56:1516–1523.PubMedCrossRefGoogle Scholar
  39. 39.
    Lai CJ, Nguyen TT, Hwang J, Stewart SL, Kwan A, McPhee SJ. Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J Cancer Educ. 2007;22:37–41.PubMedCrossRefGoogle Scholar
  40. 40.
    Hu KQ. Hepatitis B virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population. Am J Gastroenterol. 2008;103:1824–1833.PubMedCrossRefGoogle Scholar
  41. 41.
    Wong PY, Xia V, Imagawa DK, Hoefs J, Hu KQ. Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. J Immigr Minor Health. 2011;13:842–848.PubMedCrossRefGoogle Scholar
  42. 42.
    Chao SD, Chang ET, Le PV, Prapong W, Kiernan M, So SK. The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. J Immigr Minor Health. 2009;11:281–290.PubMedCrossRefGoogle Scholar
  43. 43.
    Do S. The natural history of hepatitis B in Asian Americans. Asian Am Pac Isl J Health. 2001;9:141–153.PubMedGoogle Scholar
  44. 44.
    Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:s158–s168.PubMedCrossRefGoogle Scholar
  45. 45.
    Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034–1040.PubMedCrossRefGoogle Scholar
  46. 46.
    Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology. 2008;48:1070–1078.PubMedCrossRefGoogle Scholar
  47. 47.
    Chang TT, Liaw YF, Wu SS, et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52:886–893.PubMedCrossRefGoogle Scholar
  48. 48.
    Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 2010;53:348–356.PubMedCrossRefGoogle Scholar
  49. 49.
    Tong MJ, Sun HE, Hsien C, Lu DS. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic. Dig Dis Sci. 2010;55:826–835.PubMedCrossRefGoogle Scholar
  50. 50.
    Maxwell AE, Bastani R, Chen MS Jr, Nguyen TT, Stewart SL, Taylor VM. Constructing a theoretically based set of measures for liver cancer control research studies. Prev Med. 2010;50:68–73.PubMedCrossRefGoogle Scholar
  51. 51.
    Pew Research Center. The Rise of the Asian Americans. Accessible through www.pewsocialtrends.org. 12 July 2012.

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Leeyen Hsu
    • 1
    • 6
  • Christopher L. Bowlus
    • 1
    • 3
  • Susan L. Stewart
    • 1
    • 2
  • Tram Thanh Nguyen
    • 1
    • 6
  • Julie Dang
    • 1
    • 6
  • Brian Chan
    • 1
    • 4
  • Moon S. ChenJr.
    • 1
    • 5
  1. 1.School of MedicineUniversity of California, DavisSacramentoUSA
  2. 2.Department of Public Health SciencesUniversity of California, DavisSacramentoUSA
  3. 3.Division of Gastroenterology and Hepatology, Department of Internal MedicineUniversity of California, DavisSacramentoUSA
  4. 4.UC Davis Division of Burn SurgeryClinical and Translational Science CenterSacramentoUSA
  5. 5.Division of Hematology and Oncology, Department of Internal MedicineUniversity of California, DavisSacramentoUSA
  6. 6.SacramentoUSA

Personalised recommendations